Infovac France Expert, French Association of Ambulatory Pediatrics (AFPA), St Quentin, France.
Dr. Yewale Multispeciality Hospital for Children, Navi Mumbai, India.
Hum Vaccin Immunother. 2022 Dec 31;18(1):1961468. doi: 10.1080/21645515.2021.1961468. Epub 2021 Aug 26.
Diphtheria-tetanus-pertussis (DTP) combination vaccines are a cornerstone of infant vaccinations worldwide. DTP vaccine acceptance could be impacted by sub-optimal relationships between parents and healthcare professionals (HCPs). This survey, conducted in France and India between 14/2/2020 and 26/3/2020, aimed to understand perspectives and expectations of parents and HCPs toward DTP vaccination. Participants were parents (parents/guardians of ≤3-year-old children; France: n = 1002, India: n = 1021) and HCPs (general practitioners/pediatricians initiating DTP vaccination; France: n = 300; India: n = 300) who chose to take part. A representative sample of parents was achieved via quotas and random iterative weighting to match key demographics of the target population. In India, only parents from socio-economic classes A/B/C and private HCPs were included. Whilst DTP vaccine acceptance was high among parents in France (85%) and India (98%), French HCPs overestimated parental acceptance (99% thought parents were very/fairly accepting). The proportions of parents reporting that the HCP is someone they trust versus the proportions of HCPs wanting to be seen as trusted were discrepant in France (76% versus 90%) but not India (83% versus 85%). Some surveyed parents indicated that, ideally, they would like some input in vaccine brand decisions alongside HCPs, an opinion shared by some HCPs. In France, short-term experience post-vaccination was more important to parents than HCPs, for whom long-term protection was more important. In India, these aspects were equally important to both. Increased awareness of parents' priorities and concerns regarding DTP vaccination can support HCPs in their discussions with parents and help build trust, which may impact vaccine acceptance.
白喉-破伤风-百日咳（DTP）联合疫苗是全球婴儿疫苗接种的基石。父母与医疗保健专业人员（HCP）之间关系欠佳可能会影响 DTP 疫苗的接种接受率。这项在法国和印度进行的调查于 2020 年 2 月 14 日至 3 月 26 日进行，旨在了解父母和 HCP 对 DTP 疫苗接种的看法和期望。参与者为父母（≤3 岁儿童的父母/监护人；法国：n=1002，印度：n=1021）和 HCP（启动 DTP 疫苗接种的全科医生/儿科医生；法国：n=300；印度：n=300），他们选择参与。通过配额和随机迭代加权，在法国实现了对父母的代表性样本，以匹配目标人群的关键人口统计学特征。在印度，仅包括来自社会经济阶层 A/B/C 和私人 HCP 的父母。尽管法国（85%）和印度（98%）的父母对 DTP 疫苗的接受度很高，但法国 HCP 高估了父母的接受度（99%的人认为父母非常/相当接受）。表示 HCP 是他们信任的人，而表示 HCP 希望被视为值得信任的人的父母比例在法国（76%比 90%）存在差异，但在印度（83%比 85%）则没有差异。一些接受调查的父母表示，理想情况下，他们希望与 HCP 一起参与疫苗品牌决策，一些 HCP 也有这种想法。在法国，父母认为接种疫苗后的短期经验比 HCP 更重要，而 HCP 则认为长期保护更重要。在印度，这两个方面对两者都同样重要。提高父母对 DTP 疫苗接种的重视和关注，可以支持 HCP 与父母进行讨论，并帮助建立信任，这可能会影响疫苗的接受率。
